Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
<< View More Conferences
2018 State of the Science Summit on Hematologic Malignancies in Cleveland
Oncology Conference Multimedia
View more videos >>
Dr. Dean on the Evolution of Treatment Approaches in MCL
Dr. Valent on MRD Negativity in Multiple Myeloma
Dr. Carraway on Predisposition to Acute Myeloid Leukemia
Oncology Conference Articles
Targeted Agents Beyond Ruxolitinib Necessary in Evolving MPN Paradigm
Aaron Gerds, MD, discusses the activity and drawbacks with current systemic agents in myeloproliferative neoplasms.
Combinations May Confer Benefit in MDS Management
Mikkael A. Sekeres, MD, discusses the characteristics of myelodysplastic syndrome and the evolving armamentarium of treatment.
Zonder Addresses Unanswered Questions in Newly Diagnosed Myeloma
Jeffrey A. Zonder, MD, discusses triplet regimens in multiple myeloma and patient eligibility for clinical trials.
OncLive News Network On Location: ASH 2019 Day 3
Trending Now
Anastrozole Maintains Breast Cancer Prevention Effect in Long-Term Follow-Up
Chemo-Free Regimen Matches Neoadjuvant Chemo in HR+/HER2- Breast Cancer
Thriving Therapeutics Transform Relapsed/Refractory Myeloma Paradigm
Residual Cancer Burden Predicts Patient Outcomes Across Breast Cancer Subtypes
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe